DeJarnette purchase of Swearingen called off

Article

DeJarnette purchase of Swearingen called offDeJarnette Research Systems’ efforts to add radiology information systems capabilities to its product line have been put on hold for the time being. The Towson, MD-based company’s proposed

DeJarnette purchase of Swearingen called off

DeJarnette Research Systems’ efforts to add radiology information systems capabilities to its product line have been put on hold for the time being. The Towson, MD-based company’s proposed acquisition of Swearingen Software was called off in November just before the RSNA meeting.

The unconsummated deal has left no hard feelings on either side, according to Alan Orth, director of marketing and product management for DeJarnette. The two companies have been working together for the past year to combine their technologies and develop an integrated PACS/RIS product, and there are no plans to discontinue that relationship.

In the meantime, however, DeJarnette is talking with other RIS vendors about a potential merger or alliance that would help the company develop an integrated product with a common database for entering radiology orders on a single system.

© 2000 Miller Freeman, Inc., a United News & Media company.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.